Novel naphthalenic ligands with high affinity for the melatonin receptor

Journal of Medicinal Chemistry
1992.0

Abstract

Fifteen naphthalenic bioisosteres of melatonin with variations on the N-acylamino group have been synthesized. The results provide new structure-binding relationship information for the melatonin receptor and introduce new tools for studying melatonin's physiological importance. The indole nucleus of melatonin can be substituted by naphthalene without losing binding potency. Structural variations of the N-acylamino group significantly affect binding affinity: increasing the acyl chain length to propyl (7) or butyl (8) increases affinity, further homologation or branching decreases it, and a cyclopropyl substituent (compound 13) gives the highest affinity (Kd = 3 × 10⁻¹³). The cyclopropyl group's importance is confirmed by the indolyl analogue (compound 20) showing 100-fold higher affinity. Some ligands have greater affinity than melatonin and similar in vivo biological activities. Studies on their ability to re-entrain rat activity rhythms are ongoing. Additionally, a new serotonin receptor subtype (5-HT4) was recently identified in brain and gut tissues, positively coupled to adenylate cyclase. Metoclopramide's gastroprokinetic activity and cisapride's activity are correlated with 5-HT4 agonism. SC-53116 is the first selective agonist at the 5-HT4 receptor subtype, which may be useful for treating gastrointestinal and CNS disorders.

Knowledge Graph

Similar Paper

Novel naphthalenic ligands with high affinity for the melatonin receptor
Journal of Medicinal Chemistry 1992.0
Design and Synthesis of New Naphthalenic Derivatives as Ligands for 2-[125I]Iodomelatonin Binding Sites
Journal of Medicinal Chemistry 1995.0
Synthesis and Structure-Activity Relationships of Novel Naphthalenic and Bioisosteric Related Amidic Derivatives as Melatonin Receptor Ligands
Journal of Medicinal Chemistry 1994.0
2-Substituted 5-methoxy-N-acyltryptamines: synthesis, binding affinity for the melatonin receptor, and evaluation of the biological activity
Journal of Medicinal Chemistry 1993.0
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3
European Journal of Medicinal Chemistry 2011.0
Synthesis and pharmacological evaluation of pentacyclic 6a,7-dihydrodiindole and 2,3-dihydrodiindole derivatives as novel melatoninergic ligands
Bioorganic & Medicinal Chemistry 2008.0
Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors
Bioorganic & Medicinal Chemistry Letters 2013.0
N-(Substituted-anilinoethyl)amides: Design, Synthesis, and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands
Journal of Medicinal Chemistry 2007.0
Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II
Bioorganic & Medicinal Chemistry 2009.0
SC-53116: the first selective agonist at the newly identified serotonin 5-HT4 receptor subtype
Journal of Medicinal Chemistry 1992.0